Clinical Trial Update: Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety, efficacy, and psychological effects of Bio-Alcamid for antiretroviral drug-induced facial lipoatrophy in HIV patients has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Lipoatrophy
• HIV Infection

Drugs mentioned

• Bio-Alcamid (polyalkylimide)

Snippet

Sponsor: Canadian Immunodeficiency Research Collaborative | Conditions: Human Immunodeficiency Virus, Facial Lipoatrophy | Phase 2 | Status: COMPLETED